We have identified a new mutation in the FBP (fructose 1,6-bisphosphate) aldolase A gene in a child with suspected haemolytic anaemia associated with myopathic symptoms at birth and with a subsequent diagnosis of arthrogryposis multiplex congenita and pituitary ectopia. Sequence analysis of the whole gene, also performed on the patient's full-length cDNA, revealed only a Gly 346 → Ser substitution in the heterozygous state. We expressed in a bacterial system the new aldolase A Gly 346 → Ser mutant, and the Glu 206 → Lys mutant identified by others, in a patient with an aldolase A deficit. Analysis of their functional profiles showed that the Gly 346 → Ser mutant had the same K m as the wild-type enzyme, but a 4-fold lower k cat . The Glu 206 → Lys mutant had a K m approx. 2-fold higher than that of both the Gly 346 → Ser mutant and the wild-type enzyme, and a k cat value 40 % less than the wild-type. The Gly 346 → Ser and wild-type enzymes had the same T m (melting temperature), which was approx. 6-7
INTRODUCTION
Vertebrate fructose 1,6-bisphosphate (FBP) aldolase (EC 4.1.2.13), which exists in three isoforms, namely aldolase A, B and C, catalyses the reversible conversion of FBP and fructose 1-phosphate into two triose molecules in the glycolytic, gluconeogenic and fructose metabolic pathways [1] . Aldolase B is mainly expressed in the liver, kidney and small intestine, where it serves a role in exogenous fructose utilization. Aldolase A is a ubiquitous and constitutively expressed housekeeping enzyme that drives the glycolytic metabolic pathway in most mammalian cells. Aldolase C is expressed predominantly in the brain [1] . Aldolase B deficiency has been widely described in humans, because it causes HFI [hereditary fructose intolerance; OMIM (Online Mendelian Inheritance in Man) #229600], which is an autosomal recessive disease that may induce severe liver damage, leading, in extreme cases, to death if fructose is not eliminated from the diet [2] . To date, nearly 25 HFI-related aldolase B mutants have been isolated [3] [4] [5] [6] [7] . In contrast, cases of aldolase A deficiency, which has been associated with non-spherocytic haemolytic anaemia (OMIM #103850), are much rarer [8] [9] [10] [11] [12] .
Aldolase A deficiency is an autosomal recessive trait, with alterations in the aldolase A gene leading to amino acid substitutions (Asn 128 → Gly and Glu 206 → Lys) in two of the few cases already described [10] [11] [12] . It is conceivable that, given the essential function of this enzyme in almost all human tissues, human embryos affected by severe aldolase A mutations do not survive. Bioche-mical and thermodynamic data are available for the Asn 128 → Gly mutant [10] , whereas the Glu 206 → Lys mutant has never been characterized. Here, we report a novel defect in the aldolase A gene, i.e. a natural mutation at amino acid residue 346 (Gly → Ser), which appears to be a bending site that is important for the functioning of the enzyme. We also report the expression and characterization of the Gly 346 → Ser and Glu 206 → Lys natural mutant enzymes.
EXPERIMENTAL

Materials
Restriction endonucleases were from New England Biolabs. Taq polymerase, T4 DNA ligase, IPTG (isopropyl β-D-thiogalactoside), ampicillin, PMSF and GDH/TIM (α-glycerol phosphate dehydrogenase/triose phosphate isomerase) were from Roche Molecular Biochemicals. Imidazole, FBP and NADH were from Sigma-Aldrich. The pET-16b vector and the Escherichia coli strain BL21(DE3) were purchased from Novagen.
The patient
The proband is a 7-year-old Italian boy examined at the age of 3 months [13] , in whom aldolase A deficiency was initially suspected because of muscle weakness and presumed haemolytic anaemia. Both parents are healthy and non-consanguineous. 
Genetic analysis
Genomic DNA was purified from peripheral blood leucocytes by the NaCl extraction method [14] . The whole aldolase A-coding region, the splice junctions and the promoter regions were amplified by PCR using appropriate primer pairs (GenBank ® #NT 010604). The amplified DNA fragments were automatically sequenced using fluorescence-based methods (Big Dye TM Terminator, ABI Prism 377 DNA Sequencer; PE Applied Biosystems, Foster City, CA, U.S.A.) with the ABI-Prism 377 Applied Biosystems Genetic analyser (PE Applied Biosystems). The sequence data were analysed by a visual check for heterozygous mutations. We used the ARMS (amplification refractory mutation system) analysis [15] to examine Mendelian inheritance of the Gly 346 → Ser mutation in the proband's family. DNA samples were amplified in two reactions containing 0.2 µg of genomic DNA and 1 unit Taq polymerase (PerkinElmer/Cetus). After an initial denaturing step of 1 min at 94
• C, samples were amplified for 32 cycles at 94
• C for 20 s, 55
• C for 20 s and 72
• C for 30 s. At a final volume of 50 µl, each reaction mixture contained 200 µM of each dNTP, 50 mM KCl, 10 mM Tris/HCl, pH 8.8, 2.5 mM MgCl 2 , 0.01 % (w/v) gelatin, the appropriate forward ARMS primer, a common reverse primer and an additional primer pair that amplified a β-globin gene fragment, which is an internal control of amplification conditions ( Table 1) . The results were analysed on a 2 % (w/v) agarose gel.
Total RNA extracted from the patient's peripheral blood by the QIAamp RNA Blood Mini Kit (Qiagen Inc.) was first analysed by Northern blotting using the aldolase A cDNA as a probe, and then subjected to RT (reverse transcriptase)-PCR using specific primers (plus and minus primer; see below) and the SuperScript TM III OneStep RT-PCR System (Invitrogen, Milan, Italy). The amplified fragment, corresponding to the patient's aldolase A cDNA, was subjected to automated sequencing.
Construction and expression of wild-type and mutant aldolase A
The full-length wild-type human aldolase A cDNA [16] was amplified with the forward primer containing a NdeI site (shown underlined) at the 5 -end (plus primer: 5 -GGAATTCCATATG-CCCTACCAATATCCAGC-3 ), and the reverse primer containing the aldolase A termination codon (UAA) followed by a BamHI site (also shown underlined) (minus primer: 5 -GGAATTCG-GATCCTTAATAGGCGTGGTTAG-3). The cDNA sequence was verified by automated sequencing. The amplified cDNA was cloned into the NdeI and BamHI sites of the bacterial expression vector pET-16b, downstream of a His-tag coding sequence. To select recombinant clones, E. coli XL1-Blu host cells were transformed with the vector containing the target gene. Recombinant plasmid (pET-16b/cDNA) was purified over a Qiagen column (Qiagen).
The QuickChange TM site-directed mutagenesis kit (Stratagene) was used to introduce mutations into the pET-16b/cDNA construct. Mutagenesis reactions were carried out with a PerkinElmer 9600 thermal cycler. To change the normal Glu 206 into a lysine residue, primers 5 -CAGTATGTGACCAAGAAGGTGCTGG-3 (sense) and 5 -CCAGCACCTTCTTGGTCACATACTG-3 (antisense) were synthesized. To change Gly 346 into a serine, the sense primer was 5 -CACTCCGAGCAGTCAGGCTGG-3 and the antisense primer was 5 -CCAGCCTGACTGCTCGGAGTG-3 . The parental methylated DNA was digested with DpnI, and the newly synthesized DNA was used to transform the E. coli XL1-Blu competent cells, according to the manufacturer's instructions. Recombinant mutated plasmids were purified over Qiagen columns, and their full sequences were verified by automated sequencing. Recombinant aldolase A proteins were expressed in the E. coli B strain BL21(DE3). All the wild-type, Glu 206 → Lys and Gly 346 → Ser proteins were recovered in soluble form in bacteria grown at 37
• C. Recombinant enzymes were purified on Ni 2+ / nitrilotriacetate resin (Qiagen), as described elsewhere [7, 17] . Fractions containing the bulk of the enzyme were pooled, dialysed against 20 mM Tris/HCl, pH 7.5/50 % (v/v) glycerol, and stored at − 20
• C. All purification steps were performed at 4
• C. The purity degree of each recombinant enzyme was analysed by SDS/PAGE [10 % (w/v) gel].
Molecular mass determination, denaturation profile analysis and CD spectra
Enzyme molecular masses were determined at 25
• C by co-fractionation (on FPLC) of the purified proteins with β-amylase (200 kDa), chicken ovalbumin (44 kDa) and carbonic anhydrase (29 kDa) on a 50 cm × 1.6 cm Sephadex G-200 column (Amersham Pharmacia Biotech.) in 20 mM Tris/HCl, pH 7.4/20 % (v/v) glycerol, with a flow rate of 0.2 ml/min. CD spectra were recorded at 20
• C using a Jasco J-810 spectropolarimeter equipped with a cuvette with a 0.1 cm path length. The molar ellipticity [θ ] obs is the measured ellipticity in degrees, mrw is the mean residue molecular weight, l is the optical path length of the cuvette in cm, and C is the protein concentration expressed in g · l −1 . Spectra were recorded from 190-250 nm, with a scanning speed of 20 nm/min. Thermal denaturation data on the recombinant proteins were collected using a scan rate of 1
• C/min in the range 20-80
• C. CD experiments were performed with a protein concentration of 1 mg/ml in 20 mM Tris/HCl, pH 7.2.
Aldolase A activity assays and kinetic studies
The substrate cleavage rate was determined spectrophotometrically by measuring NADH oxidation at 340 nm in a coupled assay using GDH/TIM, with FBP as the substrate [18] . Assays were conducted at 30
• C, as described previously [7] . One unit of activity corresponds to the cleavage of 1 µmol of hexose substrate/min. Specific activity was obtained by normalizing for mg of protein. For each recombinant enzyme, we ran three assays with at least two different enzyme preparations, and evaluated the K m and k cat values from double-reciprocal plots using a leastsquares method. The kinetic data that were fitted directly to the Michaelis-Menten equation gave the same k cat and K m values calculated from the double-reciprocal plot.
Molecular graphics analyses
The alterations induced by mutations in the aldolase A structure were evaluated by molecular graphics using the crystallographic structures of human and rabbit aldolase A reported in the PDB (Protein Data Bank) [19] . In particular, the effect of the mutation of Glu 206 was analysed considering its interactions in all aldolase A structures (PDB codes 1ALD, 1ADO, 2ALD, 4ALD, 6ALD, 1J4E, 1EX5, 1EWG and 1EWD) [20] [21] [22] [23] [24] [25] . Because the C-terminal region is often disordered in the aldolase A structure, we analysed the effects of the Gly 346 → Ser mutation considering only the complexes of human aldolase A (4ALD) with FBP [22] and of rabbit aldolase A with DHAP (dihydroxyacetone phosphate; 1ADO) [21] . These analyses were performed using the Insight II, PROMOTIF [26] , O [27] and PROCHECK [28] programs. Figures 3 and 4 were generated with MolScript [29] and Raster3D [30] .
RESULTS
Genetic analysis
The proband's aldolase A gene was analysed by direct sequencing of the whole coding region and of the splice junctions. We found only one alteration at the heterozygous state in exon 9 with respect to the normal gene sequence, i.e. a G → A substitution at nt 17006 (GenBank ® #NT 010604), which changes Gly 346 into a serine residue ( Figure 1A) . We confirmed the Mendelian transmission of the mutation in the family by ARMS, and established that the proband inherited the Gly 346 → Ser substitution from his father ( Figure 1B) . This novel aldolase A mutation was not found on 200 chromosomes from normal subjects, thereby excluding its presence in the normal population.
Total RNA from the patient, analysed by Northern blotting, showed a unique band for aldolase A, which was the same size as the wild-type mRNA (results not shown). Furthermore, RT-PCR gave a single amplification product corresponding to the fulllength aldolase A cDNA. Sequencing of this fragment confirmed the presence of the Gly 346 → Ser mutation at the heterozygous state in the patient. No other mutations were detected in the patient's aldolase A mRNA.
Expression and characterization of recombinant aldolase A proteins
We expressed the wild-type aldolase A protein, the Glu 206 → Lys mutant and the new aldolase A Gly 346 → Ser mutant in E. coli. The recombinant His-tagged proteins were purified to > 95 % homogeneity by Ni 2+ -affinity chromatography, as verified by SDS/PAGE (results not shown). The recombinant enzymes were expressed in bacteria grown at 37
• C, and recovered from the soluble fraction of the bacterial lysate. The purification rate was 10-12 mg/l of culture for all recombinant proteins. The molecular mass of the recombinant enzymes, determined by FPLC, was approx. 170 kDa (Figure 2A) . The enzymes remained stable at 4
• C in 20 mM Tris/HCl, pH 7.4, for at least 2 weeks, and for at least 1 month at − 20
• C in 50% (v/v) glycerol/20 mM Tris/HCl, pH 7.4. CD spectra of wild-type, Glu 206 → Lys and Gly 346 → Ser recombinant aldolases revealed nearly identical curves within experimental error, suggesting that the three enzymes share very similar secondary structures ( Figure 2B ), and therefore that the mutations did not cause major perturbations in the enzyme's secondary structure.
The analysis of the thermal stability (Table 2 , first column, and Figure 2C ) of these recombinant forms of aldolase A reveals that the T m (melting temperature) of the Gly 346 → Ser mutant (54.8 • C) is virtually identical with that of the wild-type enzyme (54.4
• C). On the other hand, the replacement of a glutamic acid in position 206 with a lysine significantly reduces the thermal stability of the enzyme (T m 48.0
• C). Analysis of the kinetic properties of aldolase A recombinant forms (Table 2) demonstrates that the Glu 206 → Lys and Gly 346 → Ser proteins display a reduced activity towards FBP, the physiological substrate of the enzyme. In particular, the reduction in specific activity was greater in the case of the Gly 346 → Ser mutant than Glu 206 → Lys. Although the catalytic efficiency of the two mutants was reduced by the same extent (i.e. to at least one-third lower compared with the wild-type enzyme), the Glu 206 → Lys and Gly 346 → Ser proteins have different k cat and K m values. In the case of the Gly 346 → Ser mutant, the decreased k cat /K m ratio is mostly due to the decreased k cat value, whereas in the case of Glu 206 → Lys, it is due mainly to the increase in K m . The intracellular FBP concentration of approx. 14 µM [31] , lower than the K m value of the recombinant wild-type enzyme, is not sufficient to saturate the Glu 206 → Lys mutant enzyme (see Table 2 ), which hence would be less active than normal in vivo. This observation explains, at the molecular level, the severe disease phenotype of haemolytic anaemia and myopathy in the patient carrying the Glu 206 → Lys mutation in the homozygous state [11] .
Molecular graphics analyses
Aldolase A is physiologically active as a tetramer composed of four monomers each characterized by an eight-membered α/β-barrel structure. The N-terminal helix and the C-terminal region are located at opposite ends of the central cavity of the barrel structure. The Gly 346 residue, conserved among vertebrate aldolase A sequences, is located in the C-terminal region of the enzyme. In aldolase A, this region is particularly flexible, and is thus frequently disordered in the various reported three-dimensional structures of the enzyme. However, a reliable tracing of this region has been obtained for human aldolase A complexed with FBP [22] and for rabbit aldolase A complexed with the reaction product DHAP [21] . Interestingly, in the AldA-DHAP complex, the Cterminus assumes different conformations in the different chains of the tetramer, depending on the binding state of each subunit (Figure 3) . In particular, when a DHAP molecule is bound to the subunit, the C-terminus folds over the surface of its own subunit [21] . On the other hand, in subunits with no DHAP bound to the active site, the C-terminus protrudes towards an intersubunit cleft of an adjacent tetramer, thereby leaving the active site fully exposed. In both the AldA-FBP and AldA-DHAP complexes, a serine residue could replace the glycine without any steric overlap, because residue 346 is exposed to the solvent. However, we underline that the main chain dihedral angles of Gly 346 in the AldA-FBP and AldA-DHAP complexes indicate that this residue assumes, in some cases, conformations that are usually unfavourable for non-glycine residues (Table 3) .
The Glu 206 residue is located on the polar side of the amphipathic helix E (residues 197-219). This residue forms a strong intrasubunit salt bridge with Arg 258 , which is the C-terminal residue of helix F (residues 244-258). Interaction between Glu 206 and Arg 258 may affect the tetramer stability, since the Arg 258 side chain is also involved in an intersubunit salt bridge with Glu 224 of an adjacent subunit (Figures 4A and B) . The aldolase A tetramer is stabilized by four Glu 206 /Arg 258 /Glu 224 clusters of charged residues ( Figure 4A ). Interestingly, Glu 206 , Glu 224 and Arg 258 are strictly conserved residues in vertebrate aldolase isoenzymes. These residues are also present in the sequences of insects and plants, such as Drosophila melanogaster and rice. The Glu 206 / Arg 258 /Glu 224 cluster ( Figure 4B ) has been detected in all vertebrate aldolase structures reported in the PDB, independently of the protein source, the binding state and the occurrence of mutations. In this framework, the replacement of Glu 206 with a positively charged lysine residue may severely perturb the structural integrity of the enzyme.
DISCUSSION
Class I aldolases are important enzymes in glycolysis. Aldolase deficiencies may lead to severe genetic diseases. In particular, aldolase B deficiency in humans is linked to the widespread HFI, which affects 1 in 2000 newborns.
Mutations in the aldolase A gene are very rare in vivo. Thus far, only two naturally occurring mutations (Asn 128 → Gly and Glu 206 → Lys) have been reported, both of which are associated with non-spherocytic haemolytic anaemia and myopathic symptoms [10, 11] . Whereas a large body of biochemical and thermodynamic data is available for Asn 128 → Gly [10] , the Glu 206 → Lys mutant has never been expressed and characterized.
Here, we report a novel naturally occurring mutation of aldolase A (Gly 346 → Ser), which has been found, in the heterozygous state, in an infant in whom an aldolase deficit was suspected, because of severe muscle weakness and presumed haemolytic anaemia. We have expressed and characterized the Gly 346 → Ser and Glu 206 → Lys mutants. Analysis of the thermal stability of the two mutants indicates that the Gly 346 → Ser enzyme is as stable as the wild-type, whereas replacement of Glu 206 with a lysine residue reduces the enzyme T m by 6.4
• C. These results may be interpreted in view of the location of the mutated sites in the three-dimensional structure of the enzyme. Indeed, Gly 346 is located in the proximity of the flexible C-terminus, whereas Glu 206 is involved in strong electrostatic interactions at the subunit interfaces of the aldolase A tetramer. Remarkably, the destabilization of the Glu 206 → Lys mutant is comparable with that reported for the disease-causing mutation, Asn 128 → Gly [10] . From the biochemical viewpoint, both Glu 206 → Lys and Gly 346 → Ser mutants have a lower catalytic efficiency than wildtype aldolase A. However, a closer evaluation of the kinetic parameters revealed that the k cat /K m ratio is reduced by different mechanisms in the two mutants. In the case of Glu 206 → Lys, both K m and k cat are significantly decreased, despite the distance [larger than 20 Å (1 Å ≡ 0.1 nm)] between the mutation site and the active site. This finding indicates that structural modifications Given the location of Gly 346 in each chain (black circles), this residue is clearly important for the flexibility of the C-terminal segment of the aldolase A protein. at the intersubunit interface may be propagated towards the activesite regions via changes in the enzyme's tertiary and quaternary structures. A different picture emerges from the analysis of the kinetic parameters of the Gly 346 → Ser mutant, which has the same K m value as the wild-type enzyme and a significantly reduced k cat . These observations are consistent with the structural data available for the aldolase A enzyme [21, 25] . Indeed, it is not surprising that wild-type aldolase A and the Gly 346 → Ser mutant have a similar affinity for FBP since, as the structure of the AldA-FBP complex shows, neither Gly 346 nor the C-terminal region directly interacts with the substrate [22] . On the other hand, the lower k cat value of the Gly 346 → Ser mutant points to an alteration in the enzyme's catalytic properties as a consequence of a decreased flexibility of the C-terminus. The latter consideration is in line with the observations that: (i) the C-terminus adopts different conformations, depending on the binding mode of the reaction product (i.e. DHAP) to aldolase A [21] ; and (ii) in aldolase A structures, Gly 346 often adopts conformations that are energetically unfavourable for non-glycine residues, such as serine. Therefore the flexibility of the C-terminal region is important for the efficiency of aldolase A function.
In conclusion, our study was prompted by the discovery of a novel in vivo mutation of human aldolase A. Not only does our investigation lend additional support to the role of the flexible Cterminal region in the enzyme function [21, 22] , but it also provides a strong indication that Gly 346 , a residue embodied within a hinge fragment at the C-terminus, is critical for the enzyme's activity.
